Target intelligence / Profile preview

SARS-CoV-2 infected cells

Molecular classification
Other
01

Overview

"SARS-CoV-2 infected cells" is a collective term describing any cell that has been invaded by the SARS-CoV-2 virus, the causative agent of COVID-19. This phrase does not specify a single molecular entity or receptor but rather denotes the infection state of various cell types susceptible to viral entry and replication. SARS-CoV-2 infection leads to characteristic changes in host cells, involving expression of viral proteins, altered host gene expression, and disruptions in cellular and organelle function. The virus typically gains entry via angiotensin-converting enzyme 2 (ACE2) and may use other co-receptors. 'SARS-CoV-2 infected cells' is not a molecularly defined therapeutic target, but rather a descriptive category useful for clinical diagnostics, research studies, or therapeutic context when targeting infected rather than uninfected cells."[1][2][4][5][6]

Other names
Cells infected by SARS-CoV-2SARS-CoV-2 positive cellsCOVID-19 infected cellsCoronavirus-infected cellsSARS2-infected cells
02

Biological functions

Other
03

Disease associations

Infection
04

Safety considerations

Biosafety requirements due to infectious riskCellular heterogeneity after infectionPotential non-specific cytotoxicity in drug testing
05

Biomarkers

Viral RNA (detected by PCR or RNAseq)Viral proteins (such as Spike or Nucleocapsid protein detected by immunostaining)

Beyond the preview

Go deeper on SARS-CoV-2 infected cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SARS-CoV-2 infected cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call